Population Health Research Institute
phri.caLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
115
Active
31
Phase 3
37
Total enrollment
495,343
Pipeline matrix
Showing 20 of 20 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Non-vitamin K oral anticoagulant | — | — | — | — | — | 1 | |
| Edoxaban | — | — | — | — | — | 1 | |
| VKA | — | — | — | — | 2 | ||
| Colchicine 0.5 MG Oral | — | — | — | — | — | 2 | |
| Rivaroxaban | — | — | — | — | — | 4 | |
| Colchicine-Placebo | — | — | — | — | — | 2 | |
| Amiodarone Hydrochloride 200 MG | — | — | — | — | — | 1 | |
| ASA | — | — | — | — | — | 1 | |
| DOAC | — | — | — | — | — | 1 | |
| Azithromycin Oral | — | — | — | — | — | 1 | |
| Warfarin | — | — | — | — | — | 1 | |
| Cytisine | — | — | — | — | — | 1 | |
| Semaglutide | — | — | — | — | — | 1 | |
| Trastuzumab | — | — | — | — | — | 1 | |
| Pertuzumab | — | — | — | — | — | 1 | |
| Trastuzumab emtansine | — | — | — | — | — | 1 | |
| Direct Oral Anticoagulant | — | — | — | — | — | 1 | |
| Higher Dose UFH | — | — | — | — | — | 1 | |
| Lower Dose UFH | — | — | — | — | — | 1 | |
| Virtual care with remote automated monitoring | — | — | — | — | — | 1 |
Next readouts
- 2024-10-08
- 2025-12
- 2025-12-31
- 2026-05-13
- 2026-07-01
- 2026-12-31
- 2027-02-03
- 2027-06
- 2028-06-30
- 2028-07-30
Top conditions
- Atrial Fibrillation22
- Stroke9
- Heart Failure7
- Myocardial Infarction6
- Cardiovascular Diseases5
- Type 2 Diabetes Mellitus5
- Surgery4
- Ischemic Stroke4
Frequently asked questions about Population Health Research Institute
- How many clinical trials does Population Health Research Institute have on ClinicalTrials.gov?
- Population Health Research Institute is listed as the lead sponsor on 115 clinical trials in ClinicalTrials.gov, 31 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Population Health Research Institute's trials are in Phase 3?
- 37 of Population Health Research Institute's trials are in Phase 3, spread across 20 active drug programs.
- What therapeutic areas does Population Health Research Institute focus on?
- Population Health Research Institute's most-studied conditions on ClinicalTrials.gov are Atrial Fibrillation, Stroke, Heart Failure, Myocardial Infarction, Cardiovascular Diseases.
- When are Population Health Research Institute's next clinical trial readouts?
- Population Health Research Institute has 10 upcoming primary-completion readouts tracked here; the soonest is “Higher vs. Lower Dose Heparin for PCI”, expected around 2024-10-08.